Cleared Traditional

POCKET TRANSCRANIAL AND VASCULAR DOPPLER SPECTRUM ANALYZER, MODEL 500P (K051739) - FDA 510(k) Clearance

Also marketed or referenced as:
PW DOPPLER ULTRAOUND PROBE, MODEL 2MPB.

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K051739 · Multigon Industries, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2005
Decision
30d
Days
Class 2
Risk

K051739 is an FDA 510(k) clearance for the POCKET TRANSCRANIAL AND VASCULAR DOPPLER SPECTRUM ANALYZER, MODEL 500P. Classified as System, Imaging, Pulsed Doppler, Ultrasonic within the IYN classification (a category covering pulsed Doppler and ultrasound imaging systems), Class II - Special Controls.

Submitted by Multigon Industries, Inc. (Yonkers, US). The FDA issued a Cleared decision on July 28, 2005 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1550 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Multigon Industries, Inc. devices

Submission Details

510(k) Number K051739 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 28, 2005
Decision Date July 28, 2005
Days to Decision 30 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
77d faster than avg
Panel avg: 107d · This submission: 30d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IYN System, Imaging, Pulsed Doppler, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYN System, Imaging, Pulsed Doppler, Ultrasonic

All 609
Devices cleared under the same product code (IYN) and FDA review panel - the closest regulatory comparables to K051739.
ACUSON CYPRESS ULTRASOUND SYSTEM
K052331 · Siemens Medical Solutions USA, Inc. · Nov 2005
ACUSON SEQUOIA ULTRASOUND SYSTEM
K052410 · Siemens Medical Solutions USA, Inc. · Sep 2005
GE LOGIQ 7 ULTRASOUND BT05
K052441 · General Electric Co. · Sep 2005
GE VIVID 7 WITH OR WITHOUT SUFFIX
K051449 · GE Medical Systems · Jun 2005
ACUSON SEQUOIA DIAGNOSTIC ULTRASOUND SYSTEM
K051139 · Siemens Medical Solutions USA, Inc. · May 2005
MODIFICATION TO ACUSON CV70 CARDIOVASCULAR SYSTEM
K050240 · Siemens Medical Solutions USA, Inc. · Feb 2005